Site-specific PEGylation of lidamycin and its antitumor activity
In this study, N-terminal site-specific mono-PEGylation of the recombinant lidamycin apoprotein (rLDP) of lidamycin (LDM) was prepared using a polyethyleneglycol (PEG) derivative (Mw 20 kDa) through a reactive terminal aldehyde group under weak acidic conditions (pH 5.5). The biochemical properties...
Main Authors: | Liang Li, Boyang Shang, Lei Hu, Rongguang Shao, Yongsu Zhen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-05-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383515000490 |
Similar Items
-
Protein PEGylation for the design of biobetters: from reaction to purification processes
by: João Henrique Picado Madalena Santos, et al.
Published: (2018-11-01) -
Lidamycin Induces Apoptosis of B-Cell Lymphoma Cells and Inhibits Xenograft Growth in Nude Mice
by: Hong FANG, et al.
Published: (2009-06-01) -
Exploring PEGylated and immobilized laccases for catechol polymerization
by: Jing Su, et al.
Published: (2018-08-01) -
Site-Specific PEGylation of Therapeutic Proteins
by: Jonathan K. Dozier, et al.
Published: (2015-10-01) -
Preparation of pegylated lumbrokinase and an evaluation of its thrombolytic activity both in vitro and in vivo
by: Mingji Jin, et al.
Published: (2013-04-01)